Related references
Note: Only part of the references are listed.The Emerging Relevance of the Cysteine Protease Cathepsin S in Disease
Donna M. Small et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2011)
Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer
Donal P. McLornan et al.
CLINICAL CANCER RESEARCH (2010)
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice
Lisa Sevenich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis
Roberta E. Burden et al.
CLINICAL CANCER RESEARCH (2009)
A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?
Miriam Koopman et al.
EUROPEAN JOURNAL OF CANCER (2009)
Cathepsin S and its inhibitor cystatin C: imbalance in uveal melanoma
Luminita Paraoan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
Monica M. Bertagnolli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genetic prognostic and predictive markers in colorectal cancer
Axel Walther et al.
NATURE REVIEWS CANCER (2009)
Role of cysteine cathepsins in matrix degradation and cell signalling
Natasa Obermajer et al.
CONNECTIVE TISSUE RESEARCH (2008)
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial
Michael S. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice
O. Vasiljeva et al.
ONCOGENE (2008)
Cysteine cathepsin proteases as pharmacological targets in cancer
Carmela Palermo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Optimal pathologic staging: Defining stage II disease
Carolyn C. Compton
CLINICAL CANCER RESEARCH (2007)
Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer
Katherine M. Bell-McGuinn et al.
CANCER RESEARCH (2007)
Interaction between human cathepsins K, L, and S and elastins - Mechanism of elastinolysis and inhibition by macromolecular inhibitors
Marko Novinec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study
George P. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cysteine Cathepsins and the cutting edge of cancer invasion
Vasilena Gocheva et al.
CELL CYCLE (2007)
Cysteine cathepsins: multifunctional enzymes in cancer
Mona Mostafa Mohamed et al.
NATURE REVIEWS CANCER (2006)
Cathepsin S expression: An independent prognostic factor in glioblastoma tumours - A pilot study
Thomas Flannery et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer
Olga Vasiljeva et al.
CANCER RESEARCH (2006)
Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors
B Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
V Gocheva et al.
GENES & DEVELOPMENT (2006)
New approaches to the adjuvant therapy of colon cancer
Al B. Benson
ONCOLOGIST (2006)
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
JA Joyce et al.
CANCER CELL (2004)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression
AM Troy et al.
EUROPEAN JOURNAL OF CANCER (2004)
Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells
D Cavallo-Medved et al.
NEOPLASIA (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular mechanisms of glioma invasiveness: The role of proteases
JS Rao
NATURE REVIEWS CANCER (2003)
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?
F Graziano et al.
ANNALS OF ONCOLOGY (2003)
The clinical significance of cathepsin S expression in human astrocytomas
T Flannery et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pericellular cathepsin B and malignant progression
S Roshy et al.
CANCER AND METASTASIS REVIEWS (2003)
Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs
J Bania et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Deficiency of the cysteine protease cathepsin S impairs microvessel growth
GP Shi et al.
CIRCULATION RESEARCH (2003)
Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B
JE Koblinski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
